Skip to main content
. 2018 Jan 16;26:e20170077. doi: 10.1590/1678-7757-2017-0077

Table 2. A) Tests of Between-Subjects Effects (Dependent Variable: Viability). B) Viability&Tukey HSD for resin types. C) Viability&Tukey HSD for cleansing tablets.

A
Source Type III Sum of Squares df Mean Square F Sig.
Corrected Model a88651.08 44 2014.80 408.41 .000
Intercept 180547.92 1 180547.92 36597.55 .000
Resin type 2953.44 2 1476.72 299.34 .000
Tablet type 22468.55 2 11234.27 2277.22 .000
Concentration 51486.42 4 12871.60 2609.11 .000
Resin type * Tablet type 6409.1 4 1602.27 324.79 .000
Resin type * Concentration 653.45 8 81.68 16.56 .000
Tablet type * Concentration 3195.23 8 399.4 80.96 .000
Resin type * Tablet type * Concentration 1484.90 16 92.81 18.81 .000
Error 444.00 90 4.93
aR Squared = .995 (Adjusted R Squared = .993)
B
(I) Resin type (J) Resin type Mean Difference (I-J) Std. Error Sig.
A D 11,40* 0.468 .000
Q 6,69* 0.468 .000
D A -11,40* 0.468 .000
Q -4,71* 0.468 .000
Q A -6,69* 0.468 .000
D 4,71* 0.468 .000
C
(I) Tablet type (J) Tablet type Mean Difference (I-J) Std. Error Sig.
Corega Polident -4,31* 0.468 .000
Fitty -29,27* 0.468 .000
Polident Corega 4,31* 0.468 .000
Fitty -24,96* 0.468 .000
Fitty Corega 29,27* 0.468 .000
Polident 24,96* 0.468 .000